Development and validation of an interpretable machine learning model for predicting Gleason score upgrade in prostate cancer
- Shu-Feng Li 1,2, Jin-Ge Zhao 3, Chen-Yi Jiang 1, Shi-Yuan Wang 1,2, Si-Yu Liu 1,2, Yi-Jun Zhang 1,2, Hao Zeng 3, Fu-Jun Zhao 1
- Shu-Feng Li 1,2, Jin-Ge Zhao 3, Chen-Yi Jiang 1
- 1Department of Urology, Shanghai General Hospital, Shanghai, China.
- 2Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- 3Department of Urology, West China Hospital of Medicine, Chengdu, China.
- 0Department of Urology, Shanghai General Hospital, Shanghai, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Machine learning accurately predicts Gleason score upgrade risk in prostate cancer patients. This tool helps identify high-risk individuals for better treatment decisions.
Area Of Science
- Urology
- Oncology
- Machine Learning
- Medical Informatics
Background
- Gleason score upgrade (GSU) can lead to underestimation of prostate cancer (PCa) aggressiveness.
- This can result in suboptimal treatment decisions for patients.
Purpose Of The Study
- Develop an interpretable machine learning model to predict GSU risk.
- Utilize readily available clinical parameters for prediction.
Main Methods
- Retrospective analysis of radical prostatectomy (RP) patients.
- Development and evaluation of nine machine learning models, including LightGBM.
- Performance assessment using ROC curves, calibration curves, decision curves, and SHAP interpretation.
Main Results
- LightGBM model achieved 84.53% AUC in the test set and 76.61% in external validation.
- Key predictors for GSU include ISUP grade, age, T stage, BMI, PSA, f/t PSA, PLR, and bilateral tumor involvement.
- An online prediction tool was created based on the model.
Conclusions
- An accurate machine learning model and online tool for GSU prediction were developed.
- Identified key factors associated with GSU.
- This approach aids clinicians in identifying high-risk patients for informed treatment planning.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

